Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3D72S | SC |
patient given MMR(Priorix) that was frozen prior to reconstitution; 53 year old patient received priorix vaccine; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 53-year-old female patient who received MMR (Priorix) (batch number 3D72S, expiry date 01-SEP-2025) for prophylaxis. Concomitant products included Priorix. On 12-FEB-2025, the patient received Priorix (subcutaneous) .5 ml. On 12-FEB-2025, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: 53 year old patient received priorix vaccine). On an unknown date, the patient experienced incorrect storage of drug (Verbatim: patient given MMR(Priorix) that was frozen prior to reconstitution). The outcome of the incorrect storage of drug and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-APR-2025 The reporter stated they given Priorix that was frozen prior reconstitution which le to, which led to incorrect storage of vaccine. The 53 year old patient received a dose of Priorix vaccine which led to inappropriate age at vaccine administration. This was 1 of 6 linked report, reported by same reporter.
PRIORIX